The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey
Parali, E, Deger, C., Ozdemir, O., Afsar, N., Aykut Aka, S., Degertekin, M., Ergene, O., Ongen, Z., Ozdemir, M., Sumer, F., Yilmaz, Z.S., Ozel, M.O.Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.672
Date:
May, 2014
File:
PDF, 82 KB
english, 2014